Previous close | 0.0100 |
Open | 0.0200 |
Bid | 0.0000 |
Ask | 0.0400 |
Strike | 17.50 |
Expiry date | 2024-06-21 |
Day's range | 0.0100 - 0.0200 |
Contract range | N/A |
Volume | |
Open interest | 3.59k |
Pfizer stock is now above its key moving averages after reporting better-than-expected first-quarter sales. Is PFE stock a buy now?
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand “Pfizer for All.” The move, reflected in a recent trademark application, aims to provide medical information, mail-order pharmacy, and telehealth services to US patients. Recent reports indicate Pfizer’s intention to include various medications, including its COVID antiviral Paxlovid and diagnostic kits, on the platform later this year, e
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.